Vexim has received regulatory approval from the Therapeutic Goods Administration to commercialise its SpineJack and the cement delivery system, Masterflow, in Australia.
According to a press release, the company is expanding its international presence whilst preparing the development of new products.
Vincent Gardès, Vexim’s chief executive officer, concludes, “This registration will enable us to have a substantial increase of our global activities. The company considers launching the exportation in Australia by the end of 2016.”